Ravidasvir

DB15652InvestigationalSmall molecule

Ravidasvir is under investigation in clinical trial NCT02961426 (Sofosbuvir Plus Ravidasvir for the Treatment of HCV Chronic Infection).

Mechanism: Pharmacologically active on Nonstructural protein 5A
Curator reviewed
Formula / weight: C₄₂H₅₀N₈O₆ · 762.912 g/mol (avg)
Code names: BI-238630 · BL-238630 · PPI-668 free base

Resolves to

Compound

Clinical / RWD

Structure

COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1=NC(=CN1)C1=CC2=C(C=C1)C=C(C=C2)C1=CC2=C(NC(=N2)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)OC)C(C)C)C=C1

Targets

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

11Clinical trialsPhase, status and sponsor resolved per trial

1Marketed productAcross 1 country and 1 labeller

1ATC codeIncluding every combination product, plus 9 drug categories

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ravidasvir, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.